Bayer AG Valuation
| BAYN Stock | EUR 19.79 0.19 0.97% |
At this time, the firm appears to be overvalued. Bayer AG NA shows a prevailing Real Value of €18.82 per share. The current price of the firm is €19.79. Our model approximates the value of Bayer AG NA from analyzing the firm fundamentals such as Current Valuation of 83.74 B, profit margin of 0.09 %, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bayer AG's price fluctuation is not too volatile at this time. Calculation of the real value of Bayer AG NA is based on 3 months time horizon. Increasing Bayer AG's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bayer stock is determined by what a typical buyer is willing to pay for full or partial control of Bayer AG NA. Since Bayer AG is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bayer Stock. However, Bayer AG's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.79 | Real 18.82 | Hype 19.79 |
The real value of Bayer Stock, also known as its intrinsic value, is the underlying worth of Bayer AG NA Company, which is reflected in its stock price. It is based on Bayer AG's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bayer AG's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bayer AG NA helps investors to forecast how Bayer stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bayer AG more accurately as focusing exclusively on Bayer AG's fundamentals will not take into account other important factors: Bayer AG Total Value Analysis
Bayer AG NA is currently anticipated to have takeover price of 83.74 B with market capitalization of 56.05 B, debt of 35.55 B, and cash on hands of 8.19 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bayer AG fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
83.74 B | 56.05 B | 35.55 B | 8.19 B |
Bayer AG Investor Information
About 47.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.37. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bayer AG NA has Price/Earnings To Growth (PEG) ratio of 1.32. The entity last dividend was issued on the 2nd of May 2022. Based on the key indicators obtained from Bayer AG's historical financial statements, Bayer AG NA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Bayer AG Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bayer AG has an asset utilization ratio of 36.66 percent. This implies that the Company is making €0.37 for each dollar of assets. An increasing asset utilization means that Bayer AG NA is more efficient with each dollar of assets it utilizes for everyday operations.Bayer AG Ownership Allocation
Bayer AG holds a total of 982.42 Million outstanding shares. 30% of Bayer AG NA outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bayer AG Profitability Analysis
The company reported the revenue of 44.08 B. Net Income was 1000 M with profit before overhead, payroll, taxes, and interest of 27.04 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bayer AG's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bayer AG and how it compares across the competition.
About Bayer AG Valuation
The stock valuation mechanism determines Bayer AG's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bayer AG. We calculate exposure to Bayer AG's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bayer AG's related companies.Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER AG is traded on Frankfurt Stock Exchange in Germany.
8 Steps to conduct Bayer AG's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bayer AG's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bayer AG's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bayer AG's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bayer AG's revenue streams: Identify Bayer AG's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bayer AG's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bayer AG's growth potential: Evaluate Bayer AG's management, business model, and growth potential.
- Determine Bayer AG's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bayer AG's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Bayer Stock analysis
When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |